Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors (Q35747137)
Jump to navigation
Jump to search
scientific article published on 14 September 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors |
scientific article published on 14 September 2012 |
Statements
1 reference
Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors (English)
1 reference
Charles S Fuchs
1 reference
Brian M Wolpin
1 reference
Jennifer A Chan
1 reference
David P Ryan
1 reference
Andrew X Zhu
1 reference
Thomas A Abrams
1 reference
Paige Malinowski
1 reference
Eileen M Regan
1 reference
Matthew H Kulke
1 reference
14 September 2012
1 reference
1 reference
19
1 reference
5
1 reference
615-623
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference